{
    "eid": "2-s2.0-85125268124",
    "title": "Cytomegalovirus infection in liver-transplanted children",
    "cover-date": "2022-02-27",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hepatology",
            "@code": "2721",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Children",
        "Cytomegalovirus",
        "Infection",
        "Liver transplantation",
        "Pediatric"
    ],
    "authors": [
        "Norrapat Onpoaree",
        "Anapat Sanpavat",
        "Palittiya Sintusek"
    ],
    "citedby-count": 3,
    "ref-count": 85,
    "ref-list": [
        "Cytomegalovirus Infection in Liver Transplant Recipients: Current Approach to Diagnosis and Management",
        "Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials",
        "Definitions of cytomegalovirus infection and disease",
        "Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection",
        "Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection",
        "Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection",
        "Changes in Cytomegalovirus Seroprevalence Among U.S. Children Aged 1-5 Years: The National Health and Nutrition Examination Surveys",
        "Earlier and higher rates of cytomegalovirus infection in pediatric liver transplant recipients as compared to adults: An observational study",
        "Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]",
        "Is cytomegalovirus infection dangerous in cytomegalovirus-seropositive recipients after liver transplantation?",
        "Cytomegalovirus infection in liver transplant recipients: updates on clinical management",
        "Management of cytomegalovirus infection and disease in liver transplant recipients",
        "A universal preemptive therapy for cytomegalovirus infections in children after live-donor liver transplantation",
        "Late cytomegalovirus infection in children: High incidence of allograft rejection and hepatitis in donor negative and seropositive liver transplant recipients",
        "Risk factors of cytomegalovirus infection after pediatric liver transplantation",
        "Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues",
        "Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus",
        "Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease",
        "Human cytomegalovirus-induced reduction of extracellular matrix proteins in vascular smooth muscle cell cultures: a pathomechanism in vasculopathies?",
        "Interferon-Y production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients",
        "QuantiFERON\u00ae-CMV assay for the assessment of cytomegalovirus cell-mediated immunity",
        "T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipients",
        "Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients",
        "Utility of CMV-Specific Immune Monitoring for the Management of CMV in Solid Organ Transplant Recipients: A Clinical Update",
        "CMV Prevention and Treatment in Transplantation: What's New in 2019",
        "A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients",
        "Impact of standardized protocols for cytomegalovirus disease prevention in pediatric solid organ transplant recipients",
        "Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation",
        "Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients",
        "Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir",
        "Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study",
        "Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients",
        "Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients",
        "Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients",
        "Plasma cytomegalovirus DNA load predicts outcomes in liver transplant recipients",
        "An international multicenter performance analysis of cytomegalovirus load tests",
        "A collaborative study to establish the 1st WHO International Standard for Epstein-Barr virus for nucleic acid amplification techniques",
        "Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir",
        "Cytomegalovirus infection after liver transplantation: current concepts and challenges",
        "Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients",
        "Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies",
        "Correlation between viral load of cytomegalovirus and tacrolimus and sirolimus levels in transplanted pediatric patients",
        "Interrelationship between Toll-like receptors and infection after orthotopic liver transplantation",
        "Mannose-binding lectin and ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation",
        "Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease",
        "Cytomegalovirus infection in pediatric patients with hepatoblastoma after liver transplantation",
        "Risk factors for early viral infections after liver transplantation",
        "Cytomegalovirus as an occupational risk in daycare educators",
        "Cytomegalovirus Infection",
        "A Prospective Study of Cytomegalovirus-Specific Cell-Mediated Immune Monitoring and Cytomegalovirus Infection in Patients With Active Systemic Lupus Erythematosus Receiving Immunosuppressants",
        "Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice",
        "Infection in solid-organ transplant recipients",
        "Cytomegalovirus infections",
        "Novel approach for the diagnosis of occult cytomegalovirus cholangitis after pediatric liver transplantation: A case report",
        "Management of cytomegalovirus infection in solid organ transplantation",
        "Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation",
        "Sensitivity of blood and tissue diagnostics for gastrointestinal cytomegalovirus disease in solid organ transplant recipients",
        "Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy",
        "Overview of the diagnosis of cytomegalovirus infection",
        "Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DNA",
        "Minimal effect of delayed sample processing on results of quantitative PCR for cytomegalovirus DNA in leukocytes compared to results of an antigenemia assay",
        "How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation",
        "Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients",
        "Infection prophylaxis and management of viral infection",
        "Cytomegalovirus disease in solid organ transplant recipients: Advances lead to new challenges and opportunities",
        "Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients",
        "Cytomegalovirus infection and ganciclovir resistance caused by UL97 mutations in pediatric transplant recipients",
        "Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis",
        "Cytomegalovirus Infection under a Hybrid Strategy in Pediatric Liver Transplantation: A Single-Center Experience",
        "Two strategies for prevention of cytomegalovirus infections after liver transplantation",
        "Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir",
        "Efficacy and Safety of a Weight-based Dosing Regimen of Valganciclovir for Cytomegalovirus Prophylaxis in Pediatric Solid-organ Transplant Recipients",
        "One Year of Preemptive Valganciclovir Administration in Children After Liver Transplantation",
        "Anti-cytomegalovirus prophylaxis in solid-organ transplant recipients",
        "Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: comparison of prophylactic oral ganciclovir and oral valganciclovir",
        "Valganciclovir: therapeutic role in pediatric solid organ transplant recipients",
        "Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy",
        "Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy",
        "Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients",
        "Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial",
        "Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity",
        "Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines",
        "Phase 1 Clinical Trial of a Replication-Defective Human Cytomegalovirus (CMV) Vaccine",
        "Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector",
        "A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain)"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": []
}